Filing Details

Accession Number:
0001127602-17-020590
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-05 18:15:55
Reporting Period:
2017-06-01
Filing Date:
2017-06-05
Accepted Time:
2017-06-05 18:15:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882095 Gilead Sciences Inc GILD Biological Products, (No Disgnostic Substances) (2836) 943047598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1334682 H Gregg Alton Gilead Sciences, Inc.
333 Lakeside Drive
Foster City CA 94404
Evp Comm&Acs Ala, Corp&Med Aff No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-06-01 5,000 $65.02 107,988 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
  2. Sale prices reported for the transactions reported here range from $65.01 to $65.05. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.